Justyna Otulakowska-Skrzynska

Justyna Otulakowska-Skrzynska

Auto-generated profile, based on publicly available information

Justyna Otulakowska-Skrzynska

A Department of Integrated Dentistry , Poznan University of Medical Sciences (PUMS) , Poznań , Poland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
AKAnna Krahel
Anna Krahel
Elzbieta PaszynskaElzbieta Paszynska
Elzbieta Paszynska
JOJustyna Otulakowska-Skrzynska
Justyna Otulakowska-Skrzynska
SRSzymon Rzatowski
Szymon Rzatowski
AHAmadeusz Hernik
Amadeusz Hernik
MDMonika Dmitrzak-Węglarz
Monika Dmitrzak-Węglarz
Background. The use of easily accessible biomarkers for assessing young patients’ health is weighty. This cohort study is aimed at measuring stress/immune biomarkers in the saliva of healthy school‐age children and comparing subgroups according to age, sex, and stress perception. Material and Methods. 503 children under 12 years old (8.7 ± 1.3) were included with anthropometric evaluation (height, waist, hip circumference, body weight, and body mass index (BMI)). Levels of opiorphin (OPI), free cortisol, alpha‐amylase (sAA), and secreted immunoglobulin (sIgA) were determined by quantitative assays (ELISA) in unstimulated saliva. Unpaired t‐test, Welch test, and Mann–Whitney U test were applied for appropriate group comparisons, and the correlation between variables was analyzed with Spearman’s rank coefficient. Results were considered significant at p < 0.05. Results. sIgA and sAA exhibited significant differences depending on age and sex: IgA (ng/mL): 86 ± 68.6 vs. 104.9 ± 72.1 for (6‐7 y.o.) and (8‐11 y.o.), respectively, and 108.1 ± 80.1 vs. 94.6 ± 62.2 for male and females, respectively; sAA (U/mL): 78.9 ± 54.4 vs. 100.5 ± 81.2 for (6‐7 y.o.) and (8‐11 y.o.). No difference related to age or sex between groups was observed for cortisol and OPI. However, OPI levels were higher and correlated to prior stress exposure in children (0.31 ± 0.4 vs. 0.26 ± 0.5 ng/mL, p = 0.031). sAA was negatively correlated to low mood self‐declaration in children in the last two weeks (r = −0.10, p = 0.045). Conclusions. sIgA and sAA can be used as sex‐ and age‐related biomarkers in children 6‐12 y.o., which is not the case for free cortisol and opiorphin. However, OPI reflected previous exposure to stress, suggesting its use for evaluating stress‐related changes in children

23 April 2019 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
Elzbieta PaszynskaElzbieta Paszynska
Elzbieta Paszynska
MRMagdalena Roszak
Magdalena Roszak
ASAgnieszka Słopień
Agnieszka Słopień
YBYves Boucher
Yves Boucher
ADAgata Dutkiewicz
Agata Dutkiewicz
MDMonika Dmitrzak-Węglarz
Monika Dmitrzak-Węglarz
Objectives. Opiorphin is a salivary peptide with analgesic and antidepressant properties. Its relationship with the hypothalamic-pituitary-adrenal, autonomic nervous and immune systems may provide understanding of chronic stress, especially in anorexia nervosa (AN). This study investigated a possible correlation between opiorphin and stress/immune biomarkers, respectively cortisol, alpha-amylase (sAA), secretory IgA (sIgA) in saliva of patients with restrictive-type of AN. Methods. A case control clinical trial was conducted in 92 AN patients (+75 healthy controls). Unstimulated salivary samples were taken during the acute stage of AN, measurements of cortisol, sAA, sIgA and opiorphin were performed with a quantitative assay (Elisa, p < 0.05). Results. AN patients displayed an increase in cortisol (p < 0.001) and sIgA (p < 0.001) but not in sAA (p = 0.279) levels. Distinct correlation between these two parameters and bodyweight indexes were observed. Opiorphin levels were neither correlated to stress and immune biomarkers, nor to salivary flow rate. Conclusions. The effect of stress responses can be reliably assessed in saliva in AN patients. The difference between sIgA and cortisol indicate that they can both be used for mental stress assessment in saliva. Modulation of opiorphin by chronic stress was not confirmed. Unchanged sAA indicates a partial adaptation of human organism to severe condition during malnutrition.

14 December 2018 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
Elzbieta PaszynskaElzbieta Paszynska
Elzbieta Paszynska
MDMonika Dmitrzak-Węglarz
Monika Dmitrzak-Węglarz
MRMagdalena Roszak
Magdalena Roszak
YBYves Boucher
Yves Boucher
ADAgata Dutkiewicz
Agata Dutkiewicz
ASAgnieszka Slopien
Agnieszka Slopien
Objectives: Opiorphin is a physiological inhibitor of peptidases inactivating endogenous opioids displaying strong analgesic properties without undesirable side effects, antidepressant properties or hormonal dependency. It might therefore play an important role in patients with painful diseases related to neuro-hormonal dysregulation of the nervous system, affecting saliva secretion and composition such as anorexia nervosa (AN). The main objective aim of this study was to compare the level of opiorphin in saliva of patients with AN to matched subjects free of eating disorders. Methods: A case–control clinical trial was conducted in 68 AN patients and 43 healthy matched control subjects. Depression symptoms were assessed with the self-scored questionnaire Beck Depression Inventory (BDI) and salivary samples were taken during the acute stage of AN (BMI <15 kg/m2) for measuring opiorphin. Opiorphin levels were measured with a quantitative assay using a commercial immunoenzymatic Elisa kit (cat no. EH1927, Wuchan, Hubei, China). Results: No statistically significant difference was found in salivary opiorphin levels between the AN and control groups, (P = 0.499, Mann–Whitney U-test). Positive correlations to duration of the disease, BDI and bodyweight in AN patients were evidenced. Conclusions: Measurement of salivary opiorphin levels cannot be used as a marker of AN but may allow new perspectives in monitoring AN in its early stages.


2 June 2025 in West Kazakhstan Medical Journal
Verified
Journal Article
Open access
PDF file
MKMadina Kurmanalina
Madina Kurmanalina
DADono M. Alimova
Dono M. Alimova
JOJustyna Otulakowska-Skrzyńska
Justyna Otulakowska-Skrzyńska
EIElnara K. Ismagulova
Elnara K. Ismagulova
BZBakyt S. Zhanalina
Bakyt S. Zhanalina
AAAruzhan M. Aitmukhanbetova
Aruzhan M. Aitmukhanbetova
Periodontitis is a chronic inflammatory disease caused by a dysbiotic oral microbiome and an altered immune response. It affects approximately 10% of the adult population and is one of the leading causes of tooth loss. Beyond its local consequences, periodontitis is closely associated with systemic diseases, including cardiovascular disorders, type 2 diabetes, rheumatoid arthritis, osteoporosis, chronic kidney disease, Alzheimer’s disease, pneumonia, pregnancy complications, and COVID-19. The main mechanisms underlying this relationship include chronic systemic inflammation, the spread of bacteria and their toxins through the bloodstream, and the activation of immune cells capable of exacerbating inflammation in other organs. For instance, bacterial lipopolysaccharides (LPS) and periodontopathogens such as Porphyromonas gingivalis can contribute to the development of atherosclerosis, endotoxemia, and autoimmune reactions. Further clinical studies are required to establish a causal relationship and develop effective treatment strategies. A deeper understanding of these mechanisms may facilitate the development of interdisciplinary approaches to the prevention and treatment of both periodontitis and related systemic diseases.